Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, Singh S, Mohamed EA, Abu Dabrh AM, Prokop LJ, Wang Z, Murad MH, Mohammed K.
Hepatology. 2016 Jan;63(1):284-306. doi: 10.1002/hep.28280. Epub 2015 Nov 13.
PMID:26566246
Viral hepatitis B: clinical and epidemiological characteristics.
Burns GS, Thompson AJ.
Cold Spring Harb Perspect Med. 2014 Oct 30;4(12):a024935. doi: 10.1101/cshperspect.a024935.
PMID:25359547
Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment.
Li J, Dong XQ, Cao LH, Zhang ZQ, Zhao WF, Shang QH, Zhang DZ, Ma AL, Xie Q, Gui HL, Zhang G, Liu YX, Shang J, Xie SB, Liu YQ, Zhang C, Wang GQ, Zhao H; China HepB Related Fibrosis Assessment Research Group.
Front Cell Infect Microbiol. 2023 Jun 16;13:1151899. doi: 10.3389/fcimb.2023.1151899. eCollection 2023.
PMID:37396307
Circulating metabolites are associated with persistent elevations of ALT in patients with chronic hepatitis B with complete viral suppression.
Zheng D, Cheng C, Tang Y, Fang Z, Gao X, Chen Y, You Q, Wang K, Zhou H, Lan Z, Sun J.
J Med Virol. 2024 Jun;96(6):e29723. doi: 10.1002/jmv.29723.